Skip to main content
logo
CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.69
+0.08 (0.78%)
Sep 4, 2026, 4:08 PM HKT

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Mainland China Revenue
21.18B20.83B25.11B
Other Asian Regions Revenue
1.25B1.26B1.18B
North America Revenue
5.90B890.21M853.04M
Europe Revenue
2.47B2.43B1.31B
Other Geographies Revenue
536.65M596.27M553.88M

Revenue

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Nervous System Revenue
8.85B7.82B9.64B
Oncology Revenue
2.16B2.20B4.40B
Anti-Infectives Revenue
3.35B3.32B4.09B
Cardiovascular Revenue
2.00B1.83B2.08B
Respiratory System Revenue
1.17B1.22B1.20B
Digestion and Metabolism Revenue
950.85M943.33M1.05B
Other Therapeutic Areas Revenue
1.31B1.45B1.26B
Total Finished Drugs Revenue
19.79B18.80B23.72B
Vitamin C Revenue
2.04B2.23B1.99B
Antibiotics Revenue
1.20B1.43B1.59B
Total Bulk Products Revenue
3.24B3.66B3.58B
License Fee Income
6.61B1.79B17.83M
Functional Food and Others Revenue
1.69B1.77B1.69B

EBIT

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Finished Drugs Segment Profit
8.76B3.87B4.83B
Vitamin C Segment Profit
51.65M191.78M211.28M
Antibiotics Segment Profit
100.74M184.43M299.18M
Total Bulk Products Segment Profit
152.38M376.21M510.45M
Functional Food and Others Segment Profit
166.07M276.06M305.29M